JPRN-jRCT2080222709已完成3 期
A Multicenter, Open-label, Long-term, Extension, Phase 3 Study to Evaluate the Safety and Efficacy of TVP-1012 at 1 mg in Early Parkinson's Disease Patients Not Treated with Levodopa
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 198
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 30age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •The participant has completed the preceding study.
- •-The participant has shown no safety issues during the study treatment in the preceding study, in the opinion of the investigator or subinvestigator.
排除标准
- •-The participant has undergone blood collection of >= 400 mL within 90 days prior to the start of treatment in this study.
- •-The participant is required to take any of the excluded medications or treatments.
- •-The participant is required surgery or hospitalization for surgery during the study period.
研究者
相似试验
进行中（未招募）
不适用
An Open-label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of oral Tesaglitazar 1 mg in patients with Type 2 Diabetes. - GALLEX 1EUCTR2004-002549-11-FIAstraZeneca AB2,100
进行中（未招募）
1 期
An unblinded, multi-center study evaluating long-term treatment with Zanubrutinib (BGB-3111) regimens in patients with blood cancer in the lymph nodesB-cell malignanciesMedDRA version: 20.0Level: LLTClassification code 10003901Term: B-cell lymphoma NOSSystem Organ Class: 100000004864EUCTR2020-000547-31-FRBeiGene, Ltd.700
进行中（未招募）
1 期
An unblinded, multi-center study evaluating long-term treatment with Zanubrutinib (BGB-3111) regimens in patients with blood cancer in the lymph nodesEUCTR2020-000547-31-CZBeiGene, Ltd.700
进行中（未招募）
1 期
An unblinded, multi-center study evaluating long-term treatment with Zanubrutinib (BGB-3111) regimens in patients with blood cancer in the lymph nodesEUCTR2020-000547-31-GRBeiGene, Ltd.700
进行中（未招募）
1 期
An unblinded, multi-center study evaluating long-term treatment with Zanubrutinib (BGB-3111) regimens in patients with blood cancer in the lymph nodesB-cell malignanciesMedDRA version: 20.0Level: LLTClassification code 10003901Term: B-cell lymphoma NOSSystem Organ Class: 100000004864EUCTR2020-000547-31-NLBeiGene, Ltd.500